Do Traders Think Ardelyx Inc (ARDX) Can Turn Around Tuesday?

Ardelyx Inc (ARDX) stock has fallen 3.88% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Ardelyx Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on ARDX!

See Full ARDX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With ARDX Stock Today?

Ardelyx Inc (ARDX) stock is lower by -2.44% while the S&P 500 has gained 0.33% as of 11:42 AM on Tuesday, Nov 28. ARDX is down -$0.11 from the previous closing price of $4.31 on volume of 1,036,074 shares. Over the past year the S&P 500 has risen 15.18% while ARDX has gained 137.85%. ARDX lost -$0.12 per share in the over the last 12 months.

More About Ardelyx Inc

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. Click Here to get the full Stock Report for Ardelyx Inc stock.